Simple Bioparticle Filtration Device Based on an Ultralow-Fouling Zwitterionic Polyurethane Membrane for Rapid Large-Volume Separation of Plasma and Viruses from Whole Blood

Journal Article · 17 May 2023 · Membranes

DOI: https://doi.org/10.3390/membranes13050524 · OSTI ID:1999978

Wang, Kun ^[1]; Seol, Hyang ^[1]; Cheng, Alex ^[2]; McKeague, Nash ^[3]; Carlson, Megan  ^[1]; Degraff, Wade ^[1]; Huang, Sijia ^[4]; Kim, Sangil  ^[1]

---

1. Univ. of Illinois, Chicago, IL (United States)
2. Univ. of Illinois, Chicago, IL (United States); New Trier High School, New Trier, IL (United States)
3. Univ. of Illinois, Chicago, IL (United States); University of Chicago Laboratory Schools, IL (United States)
4. Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)

Plasma separation from whole blood is oftent required as an essential first step when performing blood tests with a viral assay. However, developing a point-of-care plasma extraction device with a large output and high virus recovery remains a significant obstacle to the success of on-site viral load tests. Here, we report a portable, easy-to-use, cost-efficient, membrane-filtration-based plasma separation device that enables rapid large-volume plasma extraction from whole blood, designed for point-of-care virus assays. The plasma separation is realized by a low-fouling zwitterionic polyurethane-modified cellulose acetate (PCBU-CA) membrane. The zwitterionic coating on the cellulose acetate membrane can decrease surface protein adsorption by 60% and increase plasma permeation by 46% compared with a pristine membrane. The PCBU-CA membrane, with its ultralow-fouling properties, enables rapid plasma separation. The device can yield a total of 1.33 mL plasma from 10 mL whole blood in 10 min. The extracted plasma is cell-free and exhibits a low hemoglobin level. In addition, our device demonstrated a 57.8% T7 phage recovery in the separated plasma. The results of real-time polymerase chain reaction analysis confirmed that the nucleic acid amplification curve of the plasma extracted by our device is comparable to that obtained by centrifugation. With its high plasma yield and good phage recovery, our plasma separation device provides an excellent replacement for traditional plasma separation protocols for point-of-care virus assays and a broad spectrum of clinical tests.

• Research Organization: Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
• Sponsoring Organization: USDOE National Nuclear Security Administration (NNSA); USDOE Laboratory Directed Research and Development (LDRD) Program
• Grant/Contract Number: AC52-07NA27344
• OSTI ID: 1999978
• Report Number(s): LLNL-JRNL-853252; 1078363
• Journal Information: Membranes, Vol. 13, Issue 5; ISSN 2077-0375
• Publisher: MDPICopyright Statement
• Country of Publication: United States
• Language: English